Colorectal Cancer Early Screening Program of Barcelona, Spain: Indicators of the first round of a program with participation of community pharmacies

被引:25
|
作者
Buron, Andrea [1 ,2 ,3 ]
Grau, Jaume [4 ]
Andreu, Montserrat [2 ,5 ]
Auge, Josep M. [6 ]
Guayta-Escolies, Rafael [7 ]
Barau, Merce [8 ]
Macia, Francesc [1 ,2 ,3 ]
Castells, Antoni [9 ]
机构
[1] Hosp del Mar, Serv Epidemiol & Evaluac, Barcelona, Spain
[2] IMIM Inst Hosp Mar Invest Med, Barcelona, Spain
[3] Red Invest Serv Salud Enfermedades Cron REDISSEC, Barcelona, Spain
[4] Univ Barcelona, Hosp Clin, Serv Med Prevent & Epidemiol, Barcelona, Spain
[5] Hosp del Mar, Serv Digestol, Barcelona, Spain
[6] Hosp Clin Barcelona, CDB, Serv Bioquim & Genet Mol, Barcelona, Spain
[7] Consell Coll Farmaceut Catalunya, Direccio Projectes & Recerca, Barcelona, Spain
[8] Coll Oficial Farmaceut Barcelona, Barcelona, Spain
[9] Univ Barcelona, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Serv Gastroenterol,Hosp Clin, Barcelona, Spain
来源
MEDICINA CLINICA | 2015年 / 145卷 / 04期
关键词
Cancer screening; Cancer early detection; Colorectal cancer; Average-risk population; Community pharmacy services; CATALONIA; MORTALITY; GENDER;
D O I
10.1016/j.medcli.2014.05.027
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and objective: The Colorectal Cancer Screening Program of Barcelona was implemented in December 2009 and involves pharmacies for the distribution and collection of screening tests. The aim of this article is to describe the main indicators of the first round of the Program (2010-2011), based on the ones suggested by the European Union. Material and methods: The target population of the Colorectal Cancer Screening Program of Barcelona includes men and women aged 50-69 years who live in the catchment areas of Hospital Clinic and Hospital del Mar. Screening consists of biennial immunochemical fecal occult blood testing, with colonoscopy as confirmatory procedure. Results: Target population comprised 197,795 persons. Participation rate was 43.6%, was higher among women and among those aged 60 and older. 2.1% of the eligible population stated to have been already screened for colorectal cancer. Overall positivity rate was 6.2%, higher among men and with a broad variability among health care areas. The detection rates of low- and high-risk adenoma, and of invasive cancer were 9.1 parts per thousand, 21.7 parts per thousand and 3.1 parts per thousand, respectively. 48.2% of tumors were stage 1. Conclusions: These results are considered satisfactory and consistent with those obtained in other 9 programs and with European standards. Nevertheless, some areas for improvement have been identified. The high participation rate can be attributed, at least in part, to the type of test and to the involvement of community pharmacies. (C) 2014 Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:141 / 146
页数:6
相关论文
共 50 条
  • [1] CHAGAS DISEASE OPPORTUNISTIC SCREENING PROGRAM IN COMMUNITY PHARMACIES IN BARCELONA (SPAIN)
    Sanchez-Montalva, A.
    Silgado, A.
    Bagaria, G.
    Rodriguez, C.
    Cervia, A.
    Bosch, P.
    Oliveira, I.
    Goterris, L.
    Espinosa, J.
    [J]. GACETA SANITARIA, 2023, 37 : S331 - S331
  • [2] Role of community pharmacies in a population-based colorectal cancer screening program
    Vives, Nuria
    Mila, Nuria
    Binefa, Gemma
    Travier, Noemie
    Farre, Albert
    Vidal, Carmen
    Sattari, Maryam
    Bagaria, Guillermo
    Garcia, Montse
    [J]. PREVENTIVE MEDICINE, 2021, 145
  • [3] Strategies to enhance participation in a screening program for colorectal cancer in a mountain community
    Crotta, Sergio
    Dagnes, Bruna
    Grazzini, Grazia
    Senore, Carlo
    [J]. GASTROENTEROLOGY, 2008, 134 (04) : A483 - A483
  • [4] HIV/AIDS screening program in community pharmacies in the Basque Country (Spain)
    Gorostiza, Inigo
    Elizondo Lopez de Landache, Isabel
    Izagirre, Leire Braceras
    [J]. GACETA SANITARIA, 2013, 27 (02) : 164 - 166
  • [5] The Implementation and First-Round Results of a Community-Based Colorectal Cancer Screening Program in Shanghai, China
    Gong, Yangming
    Peng, Peng
    Bao, Pingping
    Zhong, Weijian
    Shi, Yan
    Gu, Kai
    Zheng, Ying
    Wu, Chunxiao
    Cai, Sanjun
    Xu, Ye
    Sheng, Jun
    Wu, Fan
    [J]. ONCOLOGIST, 2018, 23 (08): : 928 - 935
  • [6] Breast cancer screening:: First round in the population-based program in Valencia, Spain
    Vizcaíno, I
    Salas, D
    Vilar, JS
    Ruiz-Perales, F
    Herranz, C
    Ibáñez, J
    [J]. RADIOLOGY, 1998, 206 (01) : 253 - 260
  • [7] STRATEGIES TO ENHANCE PARTICIPATION IN A SCREENING PROGRAM FOR COLORECTAL CANCER
    Crotta, S.
    Dagnes, B.
    Grazzini, G.
    Senore, C.
    [J]. DIGESTIVE AND LIVER DISEASE, 2008, 40 : S118 - S119
  • [8] Evaluating the appropriateness of a community pharmacy model for a colorectal cancer screening program in Catalonia (Spain)
    Santolaya, M.
    Aldea, M.
    Grau, J.
    Estrada, M.
    Barau, M.
    Buron, A.
    Francesc, M.
    Castell, A.
    Rodriguez, C.
    Gascon, P.
    Rius, P.
    Guayta-Escolies, R.
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2017, 23 (01) : 26 - 32
  • [9] Result of the first two rounds of the colorectal cancer screening program in the Balearic Islands (Spain)
    Trelles Guzman, Marita Grimanesa
    Novell Duran, Maria Teresa
    Heredia Centeno, M. Luisa
    Garcia, Monica Florido
    Sanchez-Contador Escudero, Maria del Carmen
    Iyo Miyashiro, Eduardo Yun
    Ortega Moya, Silvia Patricia
    Miro Viamonte, Elisa
    Artigues Vives, Guillem
    Gelabert Zornoza, Joan
    Garcia Cortez, Paul David
    Lucero Pizones, Juan Antonio
    Rodriguez Hidalgo, Carolina
    Ruiz Rubi, Alicia
    Roca Salom, Maria del Pilar
    Sastre-Serrae, Jorge
    Reyes Moreno, Jose
    [J]. GASTROENTEROLOGIA Y HEPATOLOGIA, 2022, 45 : 55 - 57
  • [10] Participation in a sigmoidoscopic colorectal cancer screening program:: A pilot study
    Kremers, SPJ
    Mesters, I
    Pladdet, IE
    van den Borne, B
    Stockbrügger, RW
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2000, 9 (10) : 1127 - 1130